Patrick Peterson
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Risks and Factors
-
- Estrogen and related hormone effects
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 2
- Vascular Tumors and Angiosarcomas 2
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
-
- Sarcoma Diagnosis and Treatment 5
- Renal cell carcinoma treatment 2
- Co-authors
- Douglas J. Lanska (4 shared papers)Allen S. Melemed (3 shared papers)Aman U. Buzdar (2 shared papers)William J. John (2 shared papers)Astra M. Liepa (2 shared papers)William D. Tap (3 shared papers)Robin L. Jones (3 shared papers)Daniel J. Booser (1 shared paper)
- Journals
- Stroke (4 papers)Journal of Clinical Oncology (3 papers)Cancers (3 papers)Clinical Cancer Research (2 papers)Statistics in Biopharmaceutical Research (2 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Patrick Peterson
23 papers receiving 335 citations
Peers
Comparison fields: 5 of 65
- Oncology 124
- Genetics 91
- Cancer Research 39
- Toxicology 7
- Pulmonary and Respiratory Medicine 55
Countries citing papers authored by Patrick Peterson
This map shows the geographic impact of Patrick Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Peterson more than expected).
Fields of papers citing papers by Patrick Peterson
This network shows the impact of papers produced by Patrick Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Peterson. The network helps show where Patrick Peterson may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Peterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 59 | |
| 2 | 2003 | 54 | |
| 3 | 2021 | 37 | |
| 4 | 2006 | 32 | |
| 5 | 1995 | 32 | |
| 6 | 2016 | 30 | |
| 7 | 2012 | 25 | |
| 8 | 1995 | 18 | |
| 9 | 2010 | 13 | |
| 10 | 2023 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 1995 | 8 | |
| 13 | 1996 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 1994 | 2 | |
| 19 | 2018 | 2 | |
| 20 | Defense Contracting: Improved Insight and Controls Needed over DOD's Time-and-Materials Contracts | 2007 | 1 |
About Patrick Peterson
Patrick Peterson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Surgery and Molecular Biology, having authored 24 papers that have together received 349 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Acute Ischemic Stroke Management (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal and Anal Carcinomas (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (124 citations), Genetics (91 citations), Cancer Research (39 citations), Toxicology (7 citations) and Pulmonary and Respiratory Medicine (55 citations). Patrick Peterson has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Douglas J. Lanska, Allen S. Melemed, Aman U. Buzdar, William J. John, Astra M. Liepa, William D. Tap, Robin L. Jones, Daniel J. Booser, Pamela N. Münster and Andrew J. Wagner. Their work appears in journals such as Stroke, Journal of Clinical Oncology, Cancers, Clinical Cancer Research and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.